Peer-influenced content. Sources you trust. No registration required. This is HCN.
Drugs.com
The more targeted vaccine formulation allows for administration of a smaller mRNA dose (10 mcg/0.2 mL) while achieving “higher seroresponse rates and geometric mean neutralizing antibody titer levels.”
Allergy & Immunology October 6th 2025
Medical Professionals Reference (MPR)
Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines and superior for each of the 9 serotypes unique to Capvaxive.
Cardiology September 16th 2025
Higher vaccine efficacy (13.5% [95% CI, -7.7, 30.6]) was observed with mNexspike vs the comparator in individuals aged 65 years and older.
Clinical Pharmacology September 3rd 2025
Infectious Disease Advisor
Future monitoring of VE is required to support ongoing policy decisions around the implementation of COVID-19 vaccines.
Family Medicine/General Practice August 27th 2025
MDSpire News
Provision of antiviral therapy does not require a positive test for influenza when influenza is circulating in the community.
“Last week’s vote represents a change in process for the ACIP who usually will have topics reviewed for months by expert work groups”
Clinical Pharmacology July 31st 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS